Company Filing History:
Years Active: 2023
Title: Georg Doessinger: Innovator in Cancer Treatment
Introduction
Georg Doessinger is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of T cell receptors and peptides.
Latest Patents
Georg Doessinger holds a patent for a method related to T cell receptors and peptides derived by mutations for the treatment of cancer. The patent describes a method for providing a neopeptide-specific T cell, wherein the neopeptide-specific T cell forms a complex having a half-life (T½) of at least 50 seconds with a neopeptide-MHC monomer. This invention also includes a T cell obtainable by the method, as well as a pharmaceutical composition comprising such T cells. He has 1 patent to his name.
Career Highlights
Georg Doessinger is affiliated with the Technische Universität München, where he conducts his research and development. His work focuses on advancing the understanding and treatment of cancer through innovative approaches.
Collaborations
He has collaborated with notable colleagues in his field, including Markus Gerhard and Dirk H Busch. Their combined expertise contributes to the advancement of cancer treatment methodologies.
Conclusion
Georg Doessinger's work in developing T cell receptors and peptides represents a significant advancement in cancer treatment. His innovative approach and collaboration with esteemed colleagues highlight his commitment to improving patient outcomes.